Tegretol can be discontinued one year after stenting at the discretion of the physician’s assessment based on postoperative recovery; however, it is recommended that it be continued if recovery is poor after one year. Specific medication needs to follow the doctor’s advice. Stenting generally refers to coronary stenting, after which aspirin, in combination with Tegretol, needs to be taken correctly as prescribed by the doctor. Tegretol is an antiplatelet drug for people with acute coronary syndromes and a history of myocardial infarction. Maintenance therapy with this drug is recommended for at least 12 months after stenting. However, it should be noted that the drug may cause adverse reactions such as dizziness and headache, and its use is generally not recommended during pregnancy and lactation. If the coronary angiography is reviewed one year after the operation and the blood vessels are clear without thrombosis, Tegretol can be discontinued under the guidance of the doctor, but aspirin should be continued; however, if there are symptoms such as palpitations (rapid heartbeat, often accompanied by panic attacks), chest tightness, etc., one year after the operation, or if thrombosis is seen in the blood vessels in the review, discontinuation of the drug is not recommended. After stent implantation, it is important to use the medication correctly, and review the electrocardiogram and coronary arteriogram regularly, and do not stop the medication without authorization. Specific medication should follow the doctor’s instructions.